Leaflet: information for the user
ACICLOVIR SANDOZ CARE 50 mg/g cream
Read the entire leaflet carefully before starting to use this medication, as it contains important information for you.
Follow the administration instructions of the medication contained in this leaflet or as indicated by your doctor or pharmacist exactly.
Contents of the leaflet
This medication belongs to the group of medications called antivirals, for topical use.
It is indicated for the local relief of symptoms caused by cold sores (fever blisters), such as: itching, stinging or tingling.
You should consult a doctor if it worsens or does not improve within 10 days.
Do not use Aciclovir Sandoz Care:
Warnings and precautions
Consult your doctor or pharmacist before starting to use Aciclovir Sandoz Care.
Children and adolescents
Application in children under 12 years of age should always be done under medical supervision.
Administration in children over 12 years of age is the same as for adults, see below.
Other medications and Aciclovir Sandoz Care
Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medication, including those purchased without a prescription.
No interactions with aciclovir associated with this route of administration (topical) have been described.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
There is not enough information on the effects of administering the cream during pregnancy. Systemic administration of aciclovir to rats and rabbits has not produced teratogenic or embryotoxic effects.
Human experience is limited, so the cutaneous use of aciclovir should only be considered when the potential benefits outweigh the unknown risks.
Breastfeeding
No information is available on aciclovir levels in breast milk after topical administration.
Driving and using machines
The influence of this medication on the ability to drive and use machines is nil or insignificant.
Aciclovir Sandoz Care contains cetyl alcohol, propylene glycol, and sodium
This medication may cause local skin reactions (such as contact dermatitis) because it contains cetyl alcohol.
This medication contains 0.15 g of propylene glycol per gram of cream. Propylene glycol may cause skin irritation. This medication contains propylene glycol; do not use on open wounds or large areas of damaged skin (such as burns) without consulting your doctor or pharmacist first.
This medication contains less than 1 mmol of sodium (23 mg) per gram of cream; it is essentially "sodium-free".
This medication is for cutaneous use only on the lip.
The medication will be administered as soon as possible after the appearance of signs or symptoms of the process.
Remember to use your medication. Do not stop treatment before it is finished, as the infection caused by the virus may recur.
Adults and children over 12 years of age
Apply five times a day, approximately every four hours, except during sleep hours.
Apply a sufficient amount of product to cover the affected area with a thin layer.
Continue treatment for 5 days. If complete healing has not occurred after 5 days, treatment may be extended for another 5 days, up to a total of 10 days.
You should consult a doctor if it worsens or does not improve after 10 days.
After applying this medication, wash your hands to avoid spreading the lesion to other areas of the body or infecting others.
If you think the effect of aciclovir is too strong or too weak, inform your doctor or pharmacist.
If you use more Aciclovir Sandoz Care than you should
It is unlikely that poisoning will occur due to external use; however, consult your doctor or pharmacist immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to use Aciclovir Sandoz Care
Do not use a double dose to make up for forgotten doses; continue with the usual treatment as soon as possible.
Do not exceed the recommended application frequency or treatment duration.
If you interrupt treatment with Aciclovir Sandoz Care
Do not interrupt treatment before your doctor advises you to do so, as your healing may not be complete and your disease may recur.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone experiences them.
Rare side effects(may affect up to 1 in 100 people):
Very rare side effects(may affect up to 1 in 1,000 people):
Very rare side effects(may affect up to 1 in 10,000 people):
Prolonged use of the medication in cream may lead to sensitivity phenomena; if they appear, treatment should be discontinued and a doctor consulted.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
This medication does not require special storage conditions. Keep in the original packaging.
Do not use this medication after the expiration date shown on the packaging after CAD/EXP. The expiration date is the last day of the month indicated.
Medications should not be thrown down the drain or into the trash. Deposit the packaging and medications you no longer need at the SIGRE point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Composition of Aciclovir Sandoz Care 50 mg/g cream
Appearance of the product and package contents
White or almost white cream, presented in aluminum tubes of 2 or 15 g, packaged in cardboard boxes.
Only some package sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Sandoz Farmacéutica, S.A.
Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Manufacturer:
Liconsa S.A.
Avda. Miralcampo, Nº 7
Pol. Ind. Miralcampo (Azuqueca de Henares)
19200 – Spain
or
Reig Jofré, S.A.
Gran Capitán, 10
08970 Sant Joan Despí
Barcelona, Spain
Date of the last revision of this leaflet:July 2022
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/